Health Trials

Transcutaneous Bilirubinometry and Phototherapy

ConditionNeonatal Hyperbilirubinemia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-2
SponsorPrincess Amalia Children's Clinic

About this trial

A randomized Controlled trial comparing the use of transcutaneous bilirubinometry to serum bilirubin measurements (via blooddraws = standard care) in neonates born after a gestational age \> 32 weeks and \< 15 days of age treated with Phototherapy for neonatal hyperbilrubinemia.

Eligibility criteria

Qualifiers

Neonates with indication for phototherapy for treatment of hyperbilirubinemia

Disqualifiers

skinlesions located on the sternum interfering with transcutaneous measurement

exchange transfusion

Trial design

Treatments tested in this trial

  • Transcutaneous bilirubinometry
  • Serum bilirubin

Treatment groups

130 Participants
are divided into 2 treatment groups

Locations

1
Isala Klinieken8000 GK, ZwolleOverijssel, Netherlands

Sponsors and collaborators

Princess Amalia Children's Clinic

Lead sponsor

Source ClinicalTrials.gov